The healthcare industry encompasses a wide range of services and innovations aimed at improving patient care and medical outcomes. It includes biotechnology, pharmaceuticals, and regenerative medicine, which are critical
ZEO ScientifiX is playing a crucial role in expanding South Florida’s biotechnology sector with its focus on regenerative medicine and educational initiatives.
Genflow Biosciences has achieved significant milestones in its mid-year summary, including positive interim results from a clinical trial and collaborations that ensure non-dilutive funding. The company is strategically positioned for continued success in longevity research and animal health engagements.
ADM Tronics reported a 5% increase in revenue for fiscal year 2026, driven by advancements in its Sonotron® technology for pain management and improved regulatory compliance.
·2 min read·ADM Tronics Unlimited, Inc | OTCQB:ADMT
ZEO ScientifiX has reported a remarkable increase in revenue, achieving a 124.6% growth for the three months ending April 30, 2026, primarily driven by its allogenic biologic products. This strong performance indicates a robust market demand and solidifies the company's position in the regenerative medicine field.
New to The Street Show #760 will air on Bloomberg Television, featuring insights from industry leaders in mergers and acquisitions, biotechnology, and media technology.
ZEO ScientifiX is hosting a live educational webinar aimed at healthcare professionals to share insights from Florida's inaugural year of its stem cell law.
Protagenic Therapeutics has demonstrated the efficacy of PT00114 in reducing stress responses in rodent models, presenting a novel approach for treating stress-related disorders.
·2 min read·Protagenic Therapeutics, Inc | OTCQB:PTIX
Cardiff Lexington Corporation's Nova Ortho and Spine has added Southeastern Surgery Center in Tallahassee, Florida, to its growing network, aiming to improve patient access to orthopedic and spine services.
·2 min read·Cardiff Lexington Corporation | OTCQB:CDIX